SEEING WHAT MATTERS
We support radiologists with our AI-based tools during MRI reportings. This enables them to perform more precise and objective assessments even more quickly.
— Product Innovation: AI for Prostate Diagnosis
YOUR SOLUTION FOR AUTOMATED PROSTATE DIAGNOSIS
Our latest CE-certified product enables AI-based evaluations of prostate MRIs. Lesions are automatically detected and classified according to PI-RADS 2.1.
— Our AI-based solutions
YOUR SOFTWARE FOR MRI ASSESSMENTS FROM HEAD TO KNEE.
Sharpen your focus and save time in your daily routine, seamlessly integrated into your workflow.
Everything at a glance in your PACS
Fast analysis of MRI images integrated in your workflow
Automatically generated reports incl. norm value comparison
Highest security for your data through local hosting
Customers who trust in us.
YOUR SOLUTION FOR QUANTITATIVE NEURO-IMAGING.
Our advanced tool for the AI-based evaluation of your brain MRIs. Provides security and saves valuable time - certified and tested hundreds of thousands of times in the daily radiological routine.
Saves time on tedious tasks
through automatic segmentation of physiological structures
More safety in case of critical findings
through automatic detection of pathological structures
Saves time on tedious tasks
through automatic segmentation of physiological structures
More safety in case of critical findings
through automatic detection of pathological structures
Spedali Civili Brescia University of Brescia Italy
Ihre Radiologie, Berlin - Germany
Radiologie am Rhein - Germany
evidia GmbH
DIE RADIOLOGIE Munich
Spedali Civili Brescia University of Brescia Italy
Ihre Radiologie, Berlin - Germany
Radiologie am Rhein - Germany
Radiologist-in-Chief
evidia GmbH
DIE RADIOLOGIE Munich
Our md-suite is compatible with all common PACS providers. In addition, we are working on deeper integrations with numerous other partners.
— About mediaire
WHAT SETS
US APART.
From radiologists
for radiologists
Our products are all developed in close cooperation with radiologists. This is how we ensure that your requirements are met.
Optimized for the daily routine in radiology
Our products are proven in daily routine of hospitals and medical practices. There, high precision and fair pricing allow for large scale applications.
Highest spectrum of MRI applications on the market
Our md-suite already offers a wide range of applications. However we constantly develop new products to make your daily life even easier.
— Scientific evidence
AI in facts and figures
We offer a transparent and flexible pricing model. You pay according to volume. Without risk. No hidden costs.
Test our software free of charge and without obligation!
We offer a transparent and flexible pricing model. You pay according to volume. Without risk. No hidden costs.
Test our software
free of charge and
without obligation!
— News & Press
Dienstag, 27.07.2022
Crazy days in Rome at #AINR – our suite #mdbrain has attracted huge interest and our booth was always crowded. Moreover first local experience showing gains in diagnostic precision and efficiency was presented!
Mittwoch, 01.07.2022
Crazy days in Rome at #AINR – our suite #mdbrain has attracted huge interest and our booth was always crowded. Moreover first local experience showing gains in diagnostic precision and efficiency was presented!
Freitag, 03.05.2022
mediaire and SECTRA work together to make AI-based solutions like mdbrain available to customers globally. The full growth potential and better address the needs of large internationally operating clients.
CPT Codes for AI in Brain Diagnostics – Is the US Trend a Role-Model for the Future of AI in Europe?
In January 2023, the approval of Lecanemab sparked excitement among neurologists and radiologists, a historic breakthrough as the first promising Alzheimer's treatment. With this effective pharmaceutical option, MRI-based brain diagnostic procedures gain tremendous importance for early detection of neurodegenerative diseases.
Most Successful Year on Record: Strong Growth Through Innovation and Strategic Partnerships
As we bid farewell to an outstanding 2023, mediaire stands triumphant, experiencing exceptional growth in our customer base and product usage.
Cooperation with the bender Group for the Detection of Micrometastases
The bender Group, 100% owner of medigration GmbH, an established RIS/PACS company, is collaborating with mediaire on the development of AI image recognition software for Ferrotran®. The MRI contrast agent by SPL Medical BV, with the bender group as majority stakeholder, is currently in the final phase of clinical approval studies. With the creation of mdprostate, mediaire brings extensive experience in the development of AI image recognition software for prostate cancer to the partnership.